FNMA Discussion 08/22/2014 18:33:13 $FNMA Yes ;) The

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
FNMA Discussion 08/22/2014 18:33:13 $FNMA
Yes


The unique truth here is you are a poor devil. Time to go to rice fields.

FNMA Stock Message Board http://investorshangout.com/Fannie-Mae-FNMA-61730/

This article is currently unavailable

Is this a joke?
Gold sacks going to pay a bill as well.

http://www.marketwatch.com/story/goldman-clos...?link=sfmw
i've been thinking that could be the fhfa's primary motive for a while. it may also be what leads some in washington to claim they don't want any profits going to existing shareholders.
*Flips a penny to Mierto* there, now give your shares to me.

"Be careful what you wish for."

(you never defined 'piece of that'

Be well,

-Zargis
A huge part of that $230Bill was DTA's, but don't get me wrong.....FNMA is poised to blast off...maybe another month
No, my point is that this is not the same BAC settlement. Why would the share price rise now for a settlement that actually occurred... 7+ months ago... with full payment. done.

The BAC suit that happened recently had nothing to do with us at all. The previous one did.

I.e. you and multiple others on this board have been citing the current Department of Justice BAC settlement that has no affect on us at all, because it does not involve us.

Goldman sachs - if it is 1billion+ in a settlement, may influence the price some, however the likely reason it will not is due to the amount of investors that are either holding, or have already been scared off.

Honestly, we may be just waiting for all of these lawsuits to finish (from the FHFA) and then siphon to the government before we are released... I could see that as a motive for the FHFA. (to toss it out there)

How many FHFA suits are there left, does anyone know? I haven't bothered to keep track of them but it seems there should only be a handful left.

Be well,

-Zargis
holdouts are Nomura, HSBC and Royal Bank of Scotland.

The bank(GS) is one of only four institutions still being pursued by the FHFA, which sued 18 institutions in 2011, accusing them of misrepresenting the quality of securities sold to Fannie Mae and Freddie Mac. The other holdouts are Nomura, HSBC and Royal Bank of Scotland.

http://www.ft.com/intl/cms/s/0/b604de64-2a1a-...z3BAKa2rkP
I need a job at the FHFA. They brought in close to 230ish billion over the past few years. I'll even give up my shares to get a piece of that.
Good. They weren't able to drop fnma but was able to drop fmcc by 2 pennies.
Exactly what I am saying. The Goldman Sachs settlement is already priced in since we knew it would settle eventually. I don't see the PPS going higher because of this.
Oh, and another point... when BAC originally did settle last year/ early this year, for some 11 billion, we DID rise in share price.

Be well,

-Zargis
The difference you probably should consider is that this one (goldman sachs) is a lawsuit purported by the FHFA, rather than the DEPARTMENT OF JUSTICE - which again, HAS NOTHING to do with Fannie Mae / Freddie Mac in regards to the lawsuit. (No awards, just penalties by the DOJ effectively)

I.e. this one coming up for a billion dollars, (at a glance appears to indeed involve a faulty mortgage settlement and an award likely for F&F)

Of course a lawsuit that is not directly related to the GSEs or with an award to either will not boost share price. That's like saying "I should get a dollar because you gave james over there a dollar."

Why would our share price rise?

Regardless, most of the relevant suits will not boost much for Fannie mae until after conservatorship ends simply due to the money siphon currently in place - and the lawsuits coming to an end in the near future - as well as the smaller amounts visited.

Be well,

-Zargis
BOTH
you got it.
Dont do it barefoot or in flip-flops. I've heard too many horror stories involving power/pressure washers and bare skin. Dont want to hear another!


Do you believe they are smelling sh**t under their legs?
Why does this matter? BAC settlement did nothing. This one won't either.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 0

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 113

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Don Silvestri: NFL Vet's Service Legacy Continues

Updated Category News Views 64

More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...

Continue Reading
CORE Embraces Tech to Boost Organ Donation Efforts

Updated Category News Views 73

Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...

Continue Reading
MillerKnoll's 3D Push: Legacy Meets Innovation

Updated Category News Views 42

Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...

Continue Reading
Dotwork's AI Leap: Acquires Arcario to Revolutionize Strategy

Updated Category News Views 84

Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...

Continue Reading
Boeing's Third Quarter 2026: Progress Amid Losses

Updated Category News Views 97

Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...

Continue Reading

Top 5 Most Recently Viewed Articles

SMCP Reports Strong Sales Growth Backed by Strategic Plans

Updated Category News Views 229

Strong Sales Growth in Q3 for SMCP The latest sales report for SMCP has highlighted a solid growth trajectory in the third quarter. The performance is attributed to robust activities in the America and EMEA regions, showcasing the effectiveness of the company's strategic initiatives. Sales Overview and Highlights In the first nine months of 2025, SMCP achieved impressive...

Continue Reading
InflaRx Set to Showcase Innovations at Upcoming Investor Events

Updated Category News Views 187

InflaRx to Participate in Major Investor Conferences In a noteworthy announcement, InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company specializing in anti-inflammatory therapeutics, is gearing up for participation in two significant investor conferences in September. This engagement comes as the company continues to push boundaries in treating inflammatory...

Continue Reading
Rapid7's Participation at Major Industry Conference

Updated Category News Views 141

Rapid7 to Attend Prominent Conference Rapid7, Inc. (NASDAQ:RPD), a frontrunner in threat detection and exposure management, has recently announced its participation in a significant event: the Raymond James TMT and Consumer Conference. This notable conference will take place in New York, providing a platform where industry leaders gather to discuss innovations and...

Continue Reading
Theriva Biologics Expands Opportunities with New Offering

Updated Category News Views 136

Theriva Biologics Expands Opportunities with New Offering Theriva Biologics (NYSE American: TOVX), a clinical-stage company focused on developing innovative cancer therapeutics, has recently completed a significant public offering aimed at raising $7.5 million. This initiative is not only a financial step for Theriva but also a strategic move to enhance its research...

Continue Reading
Costco Welcomes Gina Raimondo to its Board of Directors

Updated Category News Views 211

Costco's New Board Nominee Costco Wholesale Corporation (NASDAQ: COST) has announced the nomination of Gina Raimondo to its Board of Directors. Raimondo, who has an impressive track record, served as the 40th Secretary of Commerce and held the position of Governor of Rhode Island. Her political career began in 2010 when she was elected as the Treasurer of Rhode Island....

Continue Reading